205 related articles for article (PubMed ID: 21145196)
21. Brief Report: Demographic and Genetic Associations With Markers of Small and Large Fiber Sensory Neuropathy in HIV Patients Treated Without Stavudine.
Safri AY; Gaff J; Octaviana F; Setiawan DD; Imran D; Cherry CL; Laws SM; Price P
J Acquir Immune Defic Syndr; 2020 Dec; 85(5):612-616. PubMed ID: 32925363
[TBL] [Abstract][Full Text] [Related]
22. Occurrence of stavudine-induced lactic acidosis in 3 members of an African family.
Fielder J; Rambiki K
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):236-9. PubMed ID: 20798404
[TBL] [Abstract][Full Text] [Related]
23. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.
Simpson DM; Tagliati M
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):153-61. PubMed ID: 7749792
[TBL] [Abstract][Full Text] [Related]
24. The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients.
Milinkovic A; Martinez E; López S; de Lazzari E; Miró O; Vidal S; Blanco JL; Garrabou G; Laguno M; Arnaiz JA; Leon A; Larrousse M; Lonca M; Mallolas J; Gatell JM
Antivir Ther; 2007; 12(3):407-15. PubMed ID: 17591031
[TBL] [Abstract][Full Text] [Related]
25. Stavudine-induced macrocytosis during therapy for human immunodeficiency virus infection.
Martin GJ; Blazes DL; Mayers DL; Spooner KM
Clin Infect Dis; 1999 Aug; 29(2):459-60. PubMed ID: 10476771
[No Abstract] [Full Text] [Related]
26. Improvement of dyslipidemia during different HAART regimens: tenofovir- versus stavudine-containing antiretroviral combinations.
Manfredi R
Clin Infect Dis; 2006 May; 42(9):1345-7; author reply 1347-8. PubMed ID: 16586399
[No Abstract] [Full Text] [Related]
27. Developing countries need better antiretroviral drugs.
Mykén N; Sundbeck B; Mpumilwa G; Andersson R
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(1):23-4. PubMed ID: 19171914
[No Abstract] [Full Text] [Related]
28. Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance.
Blanco F; Barreiro P; Ryan P; Vispo E; Martín-Carbonero L; Tuma P; Labarga P; Medrano J; González-Lahoz J; Soriano V
J Viral Hepat; 2011 Jan; 18(1):11-6. PubMed ID: 20088890
[TBL] [Abstract][Full Text] [Related]
29. Time for a change?
Little S; del Rio C
AIDS Clin Care; 1998 Dec; 10(12):92, 98. PubMed ID: 11366070
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the prevalence of distal symmetrical polyneuropathy and its risk factors among HAART-treated and untreated HIV infected individuals.
Shurie JS; Deribew A
Ethiop Med J; 2010 Apr; 48(2):85-93. PubMed ID: 20608012
[TBL] [Abstract][Full Text] [Related]
31. Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals.
Breen RA; Lipman MC; Johnson MA
AIDS; 2000 Mar; 14(5):615. PubMed ID: 10780724
[No Abstract] [Full Text] [Related]
32. The effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: answers and questions.
Wanke C
Clin Infect Dis; 2008 Apr; 46(8):1297-8. PubMed ID: 18444870
[No Abstract] [Full Text] [Related]
33. Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function.
Rosso R; Nasi M; Di Biagio A; Repetto E; Dentone C; Pinti M; Nemes E; Ferraresi R; Mussini C; Esposito R; Viscoli C; Cossarizza A
Pediatr Infect Dis J; 2008 Jan; 27(1):17-21. PubMed ID: 18162932
[TBL] [Abstract][Full Text] [Related]
34. Stavudine-associated peripheral neuropathy in zidovudine-naïve patients: effect of stavudine exposure and antiretroviral experience.
Scarsella A; Coodley G; Shalit P; Anderson R; Fisher RL; Liao Q; Ross LL; Hernandez JE
Adv Ther; 2002; 19(1):1-8. PubMed ID: 12008857
[TBL] [Abstract][Full Text] [Related]
35. The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients.
Tin EE; Bowonwatanuwong C; Desakorn V; Wilairatana P; Krudsood S; Pitisuttithum P
Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):362-9. PubMed ID: 15916042
[TBL] [Abstract][Full Text] [Related]
36. Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and Caucasian human immunodeficiency virus patients.
Chew CS; Cherry CL; Imran D; Yunihastuti E; Kamarulzaman A; Varna S; Ismail R; Phipps M; Aghafar Z; Gut I; Price P
Tissue Antigens; 2011 Feb; 77(2):126-30. PubMed ID: 20887379
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients.
Einsiedel L; Cherry CL; Sheeran FL; Friedhuber A; Wesselingh SL; Pepe S
Mitochondrion; 2010 Aug; 10(5):534-9. PubMed ID: 20685321
[TBL] [Abstract][Full Text] [Related]
38. Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa.
Stead D; Osler M; Boulle A; Rebe K; Meintjes G
Antivir Ther; 2008; 13(7):937-43. PubMed ID: 19043928
[TBL] [Abstract][Full Text] [Related]
39. Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
Saghayam S; Kumarasamy N; Cecelia AJ; Solomon S; Mayer K; Wanke C
Clin Infect Dis; 2007 Jan; 44(2):295-300. PubMed ID: 17173234
[TBL] [Abstract][Full Text] [Related]
40. Adverse drug reactions associated with antiretroviral therapy in South Africa.
Birbal S; Dheda M; Ojewole E; Oosthuizen F
Afr J AIDS Res; 2016 Sep; 15(3):243-8. PubMed ID: 27681148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
